Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment
Year of publication
2023
Authors
Olkkola, Aleksi M.; Tapaninen, Tuija; Tornio, Aleksi; Hauta-aho, Milka; Lapatto-Reiniluoto, Outi; Neuvonen, Mikko; Kiiski, Johanna I.; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Janne T.
Organizations and authors
University of Helsinki
Tornio Aleksi
Olkkola Aleksi M.
Backman Janne T.
Kiiski Johanna I.
Neuvonen Mikko
Niemi Mikko
Hauta-aho Milka
Lapatto-Reiniluoto Outi
Neuvonen Pertti J.
Tapaninen Tuija
University of Turku
Tornio Aleksi
Helsinki University Hospital
Tornio Aleksi
Olkkola Aleksi M.
Backman Janne T.
Kiiski Johanna I.
Neuvonen Mikko
Niemi Mikko
Hauta-aho Milka
Lapatto-Reiniluoto Outi
Neuvonen Pertti J.
Tapaninen Tuija
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Parent publication name
ISSN
Publication forum
Publication forum level
2
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Partially open publication channel
License of the publisher’s version
CC BY
Self-archived
Yes
Other information
Fields of science
Pharmacy; General medicine, internal medicine and other clinical medicine
Publication country
United Kingdom
Internationality of the publisher
International
Language
English
International co-publication
No
Co-publication with a company
No
DOI
10.1111/bcp.15932
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes